Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methotrexate 15mg/5ml oral liquid
1001030U0AAARAR
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 17.5mg/5ml oral liquid
1001030U0AAATAT
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 18mg/5ml oral liquid
1001030U0AAAXAX
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 1g/40ml solution for injection vials
0801030P0AACTCT
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 1mg/5ml oral liquid
1001030U0AAALAL
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 200mg/8ml solution for injection vials
0801030P0AAASAS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 20mg/1ml inj pre-filled syringes
1001030U0AABSBS
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 20mg/5ml oral liquid
1001030U0AAAVAV
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 22.5mg/5ml oral liquid
1001030U0AAAYAY
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/1.25ml inj pre-filled syringes
1001030U0AABPBP
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/2.5ml inj pre-filled syringes
1001030U0AABDBD
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/3ml inj pre-filled syringes
0801030P0AAFDFD
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 25mg/5ml oral liquid
1001030U0AAAAAA
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 27.5mg/0.55ml inj pre-filled syringes
1001030U0AABNBN
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 27.5mg/1.1ml inj pre-filled syringes
0801030P0AADRDR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 3.75mg/5ml oral liquid
1001030U0AAAJAJ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 30mg/1.2ml inj pre-filled syringes
0801030P0AACGCG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 30mg/1.5ml inj pre-filled syringes
1001030U0AABRBR
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 32.5mg/1.3ml inj pre-filled syringes
0801030P0AAEAEA
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 35mg/1.4ml inj pre-filled syringes
0801030P0AADNDN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 4mg/5ml oral liquid
1001030U0AAAUAU
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 500mg/20ml solution for injection vials
0801030P0AAAKAK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 50mg/2ml inj pre-filled syringes
0801030P0AADVDV
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 50mg/5ml oral liquid
1001030U0AAANAN
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 5g/200ml solution for infusion vials
0801030P0AACUCU
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.